Cure Our Ovarian Cancer is pleased to announce applications for our third research granting round have opened.
We are calling for researchers investigating low-grade serous ovarian cancer, a type of cancer that disproportionately affects young Kiwi’s to apply for the $25,000 research grant.
Specifically, research has the potential to directly benefit New Zealanders affected and/or contribute to global understanding of the disease. A panel of experienced researchers, including overseas experts will assess the proposals.
Low-grade serous carcinoma is the fourth most common ovarian cancer, accounting for 3-5% of diagnoses; it typically responds poorly to chemotherapy. Cure Our Ovarian Cancer is one of just a few charities in the world that support research on this cancer. The research we fund is crucial to improving treatment options for women.
The grant is being administered on our behalf by the Gynaecological Cancer Research Trust, otherwise known as the Graci Foundation. We are thankful for their support and expertise.
Graci is concurrently advertising for a $25,000 research grant open to any gynaecological cancer research in New Zealand. The trustees of Graci are experts in the medical field; they know that research is the key to progress and they are passionate about seeing New Zealand women benefit from the latest advancements in the field.
Applications open on July 1, 2021 and close on August 1, 2021. Researchers interested in applying can find more information on Graci’s website.
OCFNZ started as Cure Our Ovarian Cancer in 2018, with a focus on low-grade serous ovarian cancer. In 2020, we expanded our focus to include all ovarian cancer and, in 2024, we changed our name to the Ovarian Cancer Foundation New Zealand.